Correlation Between Antero Midstream and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Antero Midstream and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antero Midstream and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antero Midstream Partners and Edgewise Therapeutics, you can compare the effects of market volatilities on Antero Midstream and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antero Midstream with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antero Midstream and Edgewise Therapeutics.
Diversification Opportunities for Antero Midstream and Edgewise Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Antero and Edgewise is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Antero Midstream Partners and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Antero Midstream is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antero Midstream Partners are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Antero Midstream i.e., Antero Midstream and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Antero Midstream and Edgewise Therapeutics
Allowing for the 90-day total investment horizon Antero Midstream Partners is expected to generate 0.47 times more return on investment than Edgewise Therapeutics. However, Antero Midstream Partners is 2.11 times less risky than Edgewise Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,493 in Antero Midstream Partners on December 28, 2024 and sell it today you would earn a total of 301.00 from holding Antero Midstream Partners or generate 20.16% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Antero Midstream Partners vs. Edgewise Therapeutics
Performance |
Timeline |
Antero Midstream Partners |
Edgewise Therapeutics |
Antero Midstream and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Antero Midstream and Edgewise Therapeutics
The main advantage of trading using opposite Antero Midstream and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antero Midstream position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.Antero Midstream vs. Teekay Tankers | Antero Midstream vs. Frontline | Antero Midstream vs. DHT Holdings | Antero Midstream vs. Scorpio Tankers |
Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Transaction History View history of all your transactions and understand their impact on performance |